94 related articles for article (PubMed ID: 29266203)
1. PDGFB as a vascular normalization agent in an ovarian cancer model treated with a gamma-secretase inhibitor.
Pazos MC; Sequeira G; Bocchicchio S; May M; Abramovich D; Parborell F; Tesone M; Irusta G
J Cell Physiol; 2018 Aug; 233(8):5949-5961. PubMed ID: 29266203
[TBL] [Abstract][Full Text] [Related]
2. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
3. Gamma-secretase inhibitor DAPT suppresses glioblastoma growth via uncoupling of tumor vessel density from vessel function.
Zou Y; Cao Y; Yue Z; Liu J
Clin Exp Med; 2013 Nov; 13(4):271-8. PubMed ID: 22836313
[TBL] [Abstract][Full Text] [Related]
4. Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752.
Chen X; Gong L; Ou R; Zheng Z; Chen J; Xie F; Huang X; Qiu J; Zhang W; Jiang Q; Yang Y; Zhu H; Shi Z; Yan X
Gynecol Oncol; 2016 Mar; 140(3):537-44. PubMed ID: 26704638
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with the γ-secretase inhibitor DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling.
Wang M; Ma X; Wang J; Wang L; Wang Y
Int J Oncol; 2014 Apr; 44(4):1401-9. PubMed ID: 24535252
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of gamma-secretase in Notch1 signaling pathway as a novel treatment for ovarian cancer.
Feng Z; Xu W; Zhang C; Liu M; Wen H
Oncotarget; 2017 Jan; 8(5):8215-8225. PubMed ID: 28030808
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of Notch1 by gamma-secretase inhibition contributes to cell growth inhibition and apoptosis in ovarian cancer cells A2780.
Wang M; Wu L; Wang L; Xin X
Biochem Biophys Res Commun; 2010 Feb; 393(1):144-9. PubMed ID: 20117093
[TBL] [Abstract][Full Text] [Related]
8. Local administration of platelet-derived growth factor B (PDGFB) improves follicular development and ovarian angiogenesis in a rat model of Polycystic Ovary Syndrome.
Di Pietro M; Scotti L; Irusta G; Tesone M; Parborell F; Abramovich D
Mol Cell Endocrinol; 2016 Sep; 433():47-55. PubMed ID: 27256152
[TBL] [Abstract][Full Text] [Related]
9. Effects of an inhibitor of the γ-secretase complex on proliferation and apoptotic parameters in a FOXL2-mutated granulosa tumor cell line (KGN).
Irusta G; Pazos MC; Abramovich D; De Zúñiga I; Parborell F; Tesone M
Biol Reprod; 2013 Jul; 89(1):9. PubMed ID: 23699387
[TBL] [Abstract][Full Text] [Related]
10. Gamma secretase inhibitor impairs epithelial-to-mesenchymal transition induced by TGF-β in ovarian tumor cell lines.
Pazos MC; Abramovich D; Bechis A; Accialini P; Parborell F; Tesone M; Irusta G
Mol Cell Endocrinol; 2017 Jan; 440():125-137. PubMed ID: 27908834
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy of RY10-4 with the γ-secretase inhibitor DAPT shows promise in treating HER2-amplified breast cancer.
Su F; Zhu S; Ruan J; Muftuoglu Y; Zhang L; Yuan Q
Oncotarget; 2016 Jan; 7(4):4142-54. PubMed ID: 26716652
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Notch signaling pathway using γ-secretase inhibitor delivered by a low dose of Triton-X100 in cultured oral cancer cells.
Nasrin A; Hassan M; Ye P
Biochem Biophys Res Commun; 2018 Jan; 495(3):2118-2124. PubMed ID: 29253571
[TBL] [Abstract][Full Text] [Related]
13. [Expression of Notch1, Jagged1 and NICD in epithelial ovarian carcinomas and a preliminary study on the activity of gamma-secretase in epithelial ovarian carcinoma cell lines].
Feng Z; Wen H; Liao Q
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):780-6. PubMed ID: 25537253
[TBL] [Abstract][Full Text] [Related]
14. [Notch signaling pathway blocked by gamma-secretase inhibitor and its effect on the growth and apoptosis of SKOV3 cells].
Lu YL; Xie C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):578-81, 611. PubMed ID: 25286679
[TBL] [Abstract][Full Text] [Related]
15. Influence of γ-Secretase Inhibitor 24-Diamino-5-Phenylthiazole DAPT on Platelet Activation.
Liu G; Liu G; Chatterjee M; Umbach AT; Chen H; Gawaz M; Lang F
Cell Physiol Biochem; 2016; 38(2):726-36. PubMed ID: 26871421
[TBL] [Abstract][Full Text] [Related]
16. Gamma-secretase inhibitor does not modulate angiogenesis in colon adenocarcinoma in obese mice.
Khazaei M; Kalantari E; Saeidi H; ShabaniKia N; Tahergorabi Z; Rashidi B; Dana N; Javanmard SH
Bratisl Lek Listy; 2015; 116(4):248-51. PubMed ID: 25773953
[TBL] [Abstract][Full Text] [Related]
17. Low-dose γ-secretase inhibition increases secretion of Aβ peptides and intracellular oligomeric Aβ.
Agholme L; Clarin M; Gkanatsiou E; Kettunen P; Chebli J; Brinkmalm G; Blennow K; Bergström P; Portelius E; Zetterberg H
Mol Cell Neurosci; 2017 Dec; 85():211-219. PubMed ID: 29104140
[TBL] [Abstract][Full Text] [Related]
18. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.
Shimizu A; O'Brien KP; Sjöblom T; Pietras K; Buchdunger E; Collins VP; Heldin CH; Dumanski JP; Ostman A
Cancer Res; 1999 Aug; 59(15):3719-23. PubMed ID: 10446987
[TBL] [Abstract][Full Text] [Related]
19. γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
Mao L; Zhao ZL; Yu GT; Wu L; Deng WW; Li YC; Liu JF; Bu LL; Liu B; Kulkarni AB; Zhang WF; Zhang L; Sun ZJ
Int J Cancer; 2018 Mar; 142(5):999-1009. PubMed ID: 29047105
[TBL] [Abstract][Full Text] [Related]
20. Gamma-Secretase Inhibitor, DAPT, Prevents the Development of Retinopathy of Prematurity in a Rat Model by Regulating the Delta-Like Ligand 4/Notch Homolog-1 (DLL4/Notch-1) Pathway.
Sun W; Li J; Li Y; Zheng J; Zhang X; Huang X; Li S
Med Sci Monit; 2019 Jan; 25():492-499. PubMed ID: 30652694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
